Hydra Biosciences Private
Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Funding Status:
Late Stage Venture
Industry:
PharmTech
Technology:
Cancer
Founded Date:
2001
Headquarters:
Cambridge, Massachusetts, United States